Source:http://linkedlifedata.com/resource/pubmed/id/19289595
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-3-17
|
pubmed:abstractText |
CD103 is characteristically expressed in hairy cell leukemia (HCL), a B-lymphoproliferative disorder highly responsive to treatment with purine analogs. Other CD103+ diseases are rare and do not respond well to the same therapy, including HCL variant (HCLv) and splenic marginal zone B-cell lymphoma (SMZL) variants. We analyzed 215 cases of CD103+ B-lymphoproliferative disorders to further delineate their immunophenotypic features. Flow cytometric analysis revealed that 78.6% of all cases expressed CD25 and CD103, characteristic of classical HCL. Cases analyzed immunohistochemically were also invariably positive for annexin-A1; a subset coexpressed CD10 (33/169 [19.5%]) or BCL1 (26/65 [36.9%]). In contrast, 21.4% of cases lacked CD25, a subset of which was analyzed and was invariably negative for annexin-A1, CD10, and BCL1. The CD25- cases had variable morphologic features ranging from HCLv and SMZL to prolymphocytic leukemia and diffuse large B-cell lymphoma. Clinically, patients with CD25- disease tended to be older (P= .001), typically had leukocytosis (P= .014), and did not respond well to cladribine or pentostatin. We suggest categorizing CD103+ B-lymphoproliferative disorders into 2 groups. While HCL coexpresses CD25 and annexin-A1, diseases lacking CD25 and annexin-A1 behave clinically differently and can be separated from HCL on diagnosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2 Receptor alpha Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/alpha E integrins,
http://linkedlifedata.com/resource/pubmed/chemical/annexin-A1 receptor, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1943-7722
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
131
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
586-95
|
pubmed:meshHeading |
pubmed-meshheading:19289595-Antigens, CD,
pubmed-meshheading:19289595-Diagnosis, Differential,
pubmed-meshheading:19289595-Flow Cytometry,
pubmed-meshheading:19289595-Humans,
pubmed-meshheading:19289595-Immunohistochemistry,
pubmed-meshheading:19289595-Immunophenotyping,
pubmed-meshheading:19289595-Integrin alpha Chains,
pubmed-meshheading:19289595-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:19289595-Leukemia, Hairy Cell,
pubmed-meshheading:19289595-Lymphoma, B-Cell,
pubmed-meshheading:19289595-Receptors, Peptide
|
pubmed:year |
2009
|
pubmed:articleTitle |
Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.
|
pubmed:affiliation |
Genzyme Genetics, 521 W 57th St, New York, NY 10019, USA.
|
pubmed:publicationType |
Journal Article
|